Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adult, Agenda, analog, basket, batch, BeyondSpring, bona, constitutionality, core, Daiichi, Eisai, explore, exploring, expression, fide, Genmab, iCTC, inactivated, KSQ, lab, lessor, Mirati, Neoleukin, noncurrent, Obsidian, parent, Replimune, reprioritization, Sankyo, Sanofi, TILT, TIVDAK, Werewolf
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view